2013
DOI: 10.1517/14728222.2014.856417
|View full text |Cite
|
Sign up to set email alerts
|

Hsp60 chaperonopathies and chaperonotherapy: targets and agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
129
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
7

Relationship

4
3

Authors

Journals

citations
Cited by 126 publications
(132 citation statements)
references
References 200 publications
(84 reference statements)
3
129
0
Order By: Relevance
“…Along this line of thought, inhibition of certain Hsps known to be involved in carcinogenesis has been proposed as a potential anti-cancer treatment strategy worth testing [42][43][44]35]. Furthermore, monitoring the levels of Hsps can be a useful way of following up the response to therapy [6].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Along this line of thought, inhibition of certain Hsps known to be involved in carcinogenesis has been proposed as a potential anti-cancer treatment strategy worth testing [42][43][44]35]. Furthermore, monitoring the levels of Hsps can be a useful way of following up the response to therapy [6].…”
Section: Discussionmentioning
confidence: 99%
“…Hsp60 has been implicated in carcinogenesis via its interaction with components of the Caspase cascade that leads to apoptosis. However, opinions about the role of this chaperone in carcinogenesis, and in apoptosis in particular, differ and it is not yet clear when and how Hsp60 is pro-apoptotic (i.e., it acts as an anti-cancer factor) or the contrary, namely it works in favor of the tumor by interfering with apoptosis [5][6][7][8][9][10].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…High doses of doxorubicin (640 and 1280 nM) decreased H292 cell viability inducing apoptotic cell death, as suggested by flow cytometry analysis (see later). On the basis of these results, three subapoptotic doses (20,40, and 80 nM) were chosen to evaluate doxorubicin effect after 5 days of treatment. Morphological changes were already visible starting at 20 nM of doxorubicin.…”
Section: Inhibition Of Growth and Morphological Changes In Lung Cancementioning
confidence: 99%
“…The mitochondrial chaperonin Hsp60 also named HSPD1 [17] was found in multiple subcellular sites and function in the folding and intracellular trafficking of many proteins [18,19]. Hsp60 has been found elevated in a large number of human carcinomas, which opens novel perspectives for cancer diagnosis and therapy targeting Hsp60 [20,21]. The chaperonin can activate the immune system [22] and can have both, pro-survival and pro-death functions, depending on tissue, cell type, and apoptosis inducers [23].…”
Section: Introductionmentioning
confidence: 99%